PUBLISHER: Grand View Research | PRODUCT CODE: 1571415
PUBLISHER: Grand View Research | PRODUCT CODE: 1571415
The global honey dressing market size is anticipated to reach USD 47.07 million by 2030, growing at a CAGR of 4.91% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is significantly driven by the increasing prevalence of chronic wounds and the growing awareness of the therapeutic benefits of honey in wound care. Chronic wounds, such as diabetic ulcers, venous leg ulcers, and pressure sores are becoming more common due to factors such as an aging population and rising incidences of diabetes. For instance, in January 2024, as per the American Heart Association (AHA), there are 9.7 million adults with undiagnosed diabetes and 29.3 million with a diagnosis of diabetes.
The increasing preference for natural and organic products among healthcare professionals and patients is a significant driver of the market. Honey has been recognized for its antimicrobial properties due to its high sugar content, low pH, and presence of hydrogen peroxide, making it effective against a wide range of pathogens. In March 2023, the International Wound Journal published a study that performed a meta-analysis to evaluate the impact of Honey Dressing (HD) on the treatment of Diabetic Foot Ulcers (DFU). It was found that the use of HD on DFUs resulted in a notably increased rate of wound healing and reduced the time needed for the wounds to heal, compared to the control group.
The COVID-19 pandemic had a significant impact on the market. The pandemic caused interruptions in the global supply chain, affecting the production and distribution of honey dressings. Lockdowns, restrictions on movement, and reduced workforce availability led to delays in manufacturing and shipping. With heightened awareness of infection control during the pandemic, there was increased interest in wound care products with antimicrobial properties. Honey dressings, known for their antibacterial effects, have seen some increased attention in specific segments of the market focused on preventing wound infections. The economic downturn caused by the pandemic led to reduced healthcare budgets and lower consumer spending in some regions. This affected the overall market for wound care products, including honey dressings, as hospitals and individuals sought to cut costs.
Strick regulatory frameworks set by entities like the FDA in the U.S. and the EMA in Europe pose significant barriers to the honey dressing industry's expansion. These authorities demand rigorous evidence of efficacy and safety through detailed clinical testing and assessments for medical products, including those based on honey for treating wounds. The exhaustive and protracted nature of these regulatory processes can result in delayed market entry for new products and elevate production expenses, thus hampering the growth prospects of the honey dressing market. In June 2023, Medline Industries LP recalled TheraHoney Wound Gel following a sterilization dose audit failure reported by the manufacturer, who did not increase the dose post-failure in accordance with ISO 11137.